Enduring Material

HER 2 + Breast Cancer
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
Temple Health

7600 Central Avenue
Philadelphia, PA 19111
General Information
Monday, February 7, 2022 - Saturday, December 31, 2022
Fox Chase Cancer Center
Virtual Conference Room
20th Annual Highlights of the 2021 San Antonio Breast Cancer Symposium
Temple Health
References - available in the presentation slides.
Objectives
  • Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant, integrate new findings into the management of patients with breast cancer and premalignant breast disease.
  • When clinically relevant, apply new strategies for optimizing existing treatments into the management of these patients.
  • Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.
Presentations and Speakers
HER 2 + Breast Cancer
  • Lori J Goldstein, MD
Available Credits/Points
  • Temple Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
Disclosure Statements
Lori J Goldstein, MD, Program Director, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Daiichi Sankyo - DSMB - Relationship Has Not Ended
• Genentech - Advisory Committee Member - Relationship Ended
• Eisai - Advisory Committee Member - Relationship Has Not Ended
• Astra Zeneca - Advisory Committee Member - Relationship Ended
• Merck - Advisory Committee Member - Relationship Has Not Ended
• Exact Sciences - Advisory Committee Member - Relationship Ended
• Immunomedics - Advisory Committee Member - Relationship Ended
• Biovica Divitum - Advisory Committee Member - Relationship Ended

All relevant financial relationships with ineligible companies have been mitigated.
Planners and other Administrative Support:
Lori J Goldstein, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Daiichi Sankyo - DSMB - Relationship Has Not Ended
  • Genentech - Advisory Committee Member - Relationship Ended
  • Eisai - Advisory Committee Member - Relationship Has Not Ended
  • Astra Zenica - Advisory Committee Member - Relationship Ended
  • MERCK - Advisory Committee Member - Relationship Has Not Ended
  • Exact Sciences - Advisory Committee Member - Relationship Ended
  • Immunomedics - Advisory Committee Member - Relationship Ended
  • Biovica Divitum - Advisory Committee Member - Relationship Ended
All of the relevant financial relationships listed for these individuals have been mitigated.

Accreditation Statement
  • Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Test Information
80 %
100 %
2/7/2022
Continue to Enduring Material